Treatment of generalized granuloma annulare with dupilumab

Xiaoting SongBeijing Key Laboratory of molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China

https://orcid.org/0000-0002-2268-4402 View further author information

Zirui ChenBeijing Key Laboratory of molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Department of Dermatology and Venereology, Peking University First Hospital, Beijing, ChinaView further author information

Zuotao ZhaoBeijing Key Laboratory of molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China

https://orcid.org/0000-0002-9595-6050 View further author information

Aiping WangBeijing Key Laboratory of molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Department of Dermatology and Venereology, Peking University First Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information

References

Min MS, Wu J, He H, et al. Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and janus kinase pathways. J Am Acad Dermatol. 2020;83:63–70.
PubMed Web of Science ®Google Scholar
Asai J. What is new in the histogenesis of granulomatous skin diseases? J Dermatol. 2017;44:297–303.
PubMed Web of Science ®Google Scholar
Cruz SA, Stein SL. The clinical presentation and comorbidities associated with granuloma annulare in the pediatric population: a retrospective study. Skinmed. 2022;20:24–28.
PubMedGoogle Scholar
Joshi TP, Chen V, Dong JL, et al. Atopic comorbidities associated with granuloma annulare: a Case-Control study in the all of Us database. J Am Acad Dermatol. 2023. DOI:10.1016/j.jaad.2023.02.012
Web of Science ®Google Scholar
Song EJ, Bezecny J, Farrer S. Recalcitrant generalized granuloma annulare treated successfully with dupilumab. JAAD Case Rep. 2021;7:1–2.
PubMedGoogle Scholar
Phelps-Polirer K, Alkhatib BL, Davis C. Generalized granuloma annulare associated with dupilumab therapy. Cureus. 2022;14:e27439.
PubMed Web of Science ®Google Scholar

Treatment of generalized granuloma annulare with dupilumab

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of generalized granuloma annulare with dupilumab

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date